Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results of a multicenter study.

Auteurs : Stamatopoulos B, Smith T, Crompot E, Pieters K, Clifford R, Mraz M, Robbe P, Burns A, Timbs A, Bruce DR, Hillmen P, Meuleman N, Mineur P, Firescu R, Maerevoet M, de Wilde V, Efira AA, Philippé J, Verhasselt B, Offner F, Sims D, Heger A, Dreau H, Schuh A
Jaar : 2018
Journal : Clin Cancer Res
Volume : 24(20)
Pagina's : 5048-5057

Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation.

Auteurs : Cilla N, Vercruyssen M, Ameye L, Paesmans M, de Wind A, Heimann P, Meuleman N, Bron D
Jaar : 2018
Journal : Rev Med Brux

Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation.

Auteurs : Fostier K, Caers J, Meuleman N, Broos K, Corthals J, Thielemans K, Schots R, De Keersmaecker B
Jaar : 2018
Journal : Oncotarget
Volume : 9
Pagina's : 20476-20489

The Micronome of Mesenchymal Stromal Cells is partially responsive to Inflammation.

Auteurs : Fayyad-Kazan H, Fayyad-Kazan M, Merimi M, Meuleman N, Bron D, Lagneaux L, Najar M
Jaar : 2018
Journal : Cell Biol Int
Volume : 42(2)
Pagina's : 254-260

Advanced Glycation End-Products-, C-Type Lectin- and Cysteinyl/ Leukotriene-Receptors in Distinct Mesenchymal Stromal Cell Populations: Differential Transcriptional Profiles in Response to Inflammation.

Auteurs : Najar M, Fayyad-Kazan M, Raicevic G, Fayyad-Kazan H, Meuleman N, Bron D, Lagneaux L
Jaar : 2018
Journal : Cell J
Volume : 20
Pagina's : 250-258

Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture.

Auteurs : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Jaar : 2018
Journal : Mol Cell Biochem
Volume : 447(1-2)
Pagina's : 111-124

Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation.

Auteurs : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Jaar : 2018
Journal : J Cell Commun Signal
Volume : 12(4)
Pagina's : 673-688

Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts.

Auteurs : Najar M, Krayem M, Merimi M, Burny A, Meuleman N, Bron D, Raicevic G, Lagneaux L
Jaar : 2018
Journal : Inflamm Res
Volume : 67(6)
Pagina's : 467-477

Immunohematology Mesenchymal Stromal Cell-based Therapy: From Research to Clinic.

Auteurs : Najar M, Krayem M, Meuleman N, Bron D, Hélène B, Lagneaux L
Jaar : 2018
Journal : Appl Immunohistochem Mol Morphol
Volume : 26(3)
Pagina's : e26-e43

Immunomodulatory effects of foreskin mesenchymal stromal cells (FSK-MSCs) on natural killer (NK) cells.

Auteurs : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Jaar : 2018
Journal : J Cell Physiol
Volume : 233(7)
Pagina's : 5243-54

Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review.

Auteurs : Najar M, Krayem M, Meuleman N, Bron D, Lagneaux L
Jaar : 2017
Journal : Immune Netw
Volume : 17
Pagina's : 89-102

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.

Auteurs : Attal M, Lauwers-Cances V, Hulin C, Leleu X, Caillot D, Escoffre M, Arnulf B, Macro M, Belhadj K, Garderet L, Roussel M, Payen C, Mathiot C, Fermand JP, Meuleman N, Rollet S, Maglio ME, Zeytoonjian AA, Weller EA, Munshi N, Anderson KC, Richardson PG, Facon T, Avet-Loiseau H, Harousseau JL, Moreau P
Jaar : 2017
Journal : N Engl J Med
Volume : 376
Pagina's : 1311-1320

Data on HO-1 and CD200 protein secretion during T-cells and mesenchymal stromal cells co-cultures.

Auteurs : Fayyad-Kazan M, Fayyad-Kazan H, Merimi M, Meuleman N, Bron D, Lagneaux L, Najar M
Jaar : 2017
Journal : Data Brief
Volume : 11
Pagina's : 442-445

Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B-cells from apoptosis, enhance their migration and induce gene expression modifications.

Auteurs : Crompot E, Van Damme M, Pieters K, Vermeersch M, Perez-Morga D, Mineur P, Maerevoet M, Meuleman N, Bron D, Lagneaux L, Stamatopoulos B
Jaar : 2017
Journal : Haematologica
Volume : 102(9)
Pagina's : 1594-1604

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.

Auteurs : Van Damme M, Crompot E, Meuleman N, Maerevoet M, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Jaar : 2016
Journal : Clin Epigenetics
Volume : 8
Pagina's : 132

Serum free light chains should be the target of response evaluation in light chain multiple myeloma rather than urines.

Auteurs : Dejoie T, Corre J, Caillon H, Hulin C, Perrot A, Caillot D, Boyle E, Chretien ML, Fontan J, Belhadj K, Brechignac S, Decaux O, Voillat L, Rodon P, Fitoussi O, Araujo C, Benboubker L, Fontan C, Tiab M, Godmer P, Luycx O, Allangba O, Pignon JM, Fuzibet JG, Legros L, Stoppa AM, Dib M, Pegourie B, Orsini-Piocelle F, Karlin L, Arnulf B, Roussel M, Garderet L, Mohty M, Meuleman N, Doyen C, Lenain P, Macro M, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H
Jaar : 2016
Journal : Blood
Volume : 128(25)
Pagina's : 2941-48

Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells.

Auteurs : Najar M, Fayyad-Kazan M, Fayyad-Kazan H, Meuleman N, Bron D, Lagneaux L
Jaar : 2016
Journal : Data Brief
Volume : 8
Pagina's : 1111-4

Performances of the H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adult and Pediatric Patients.

Auteurs : Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, Corazza F
Jaar : 2016
Journal : Am J Clin Pathol
Volume : 145(6)
Pagina's : 862-70

Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells.

Auteurs : André T, Najar M, Stamatopoulos B, Pieters K, Pradier O, Bron D, Meuleman N, Lagneaux L
Jaar : 2015
Journal : Cancer Immunol Immunother
Volume : 64(2)
Pagina's : 213-24

Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs].

Auteurs : Bron D, de Wind R, Cantinieaux B, Woff E, Roelandts M, Moerman C, Lemort M, Heimann P, de Wilde V, Meuleman N, Maerevoet M
Jaar : 2015
Journal : Rev Med Brux
Volume : 36
Pagina's : 237-47